Regarding AD, the levels of DRP1 are frequently increased in postmortem tissues while mitochondrial fusion proteins Mitofusin 1 (MFN1) and Mitofusin 2 (MFN2) are reduced in these tissues. This evidence concerns the gene DNM1L and Alzheimer disease.